Meribank Biotech Co., Ltd
4724.TWO
Get informed when a big investor buys or sells
+ FollowMarket Cap$993.36M
Close$
Share Statistics
| Market cap | $993.36 Million |
|---|---|
| Enterprise Value | $2.03 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.89 |
| Beta | 0.43 |
| Outstanding Shares | 95,976,400 |
Return
| Return on Equity | -17.14% |
|---|---|
| Return on Assets | -7.33% |
| Return on Invested Capital | -6.13% |
Valuation & Multiples
| P/E Ratio | -7.19 |
|---|---|
| PEG | -2.56 |
| Price to Sales | 1.15 |
| Price to Book Ratio | 0.86 |
| Enterprise Value to Revenue | 2.27 |
| Enterprise Value to EBIT | -13.23 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.54 |
| Debt to Equity | 0.94 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Meribank Biotech Co., Ltd
142 employees
CEO: Jian-Fang Cai Meribank Biotech Co., Ltd, established in 2013 and headquartered in Taipei City, Taiwan, is a company dedicated to the cultivation, advancement, and banking of mesenchymal stem cells. The firm specializes in the preservation of various c...